Initial series of magnetic resonance imaging (MRI)-fusion targeted prostate biopsy using the first transperineal targeted platform available in the USA.

ABSTRACT:

Objectives

To describe a step-by-step guide for using the first transperineal targeted prostate biopsy platform available in the USA.

Patients and methods

A total of 32 men with elevated prostate-specific antigen (PSA) levels were diagnosed with a region of interest on multiparametric magnetic resonance imaging (mpMRI) between February 2017 and January 2018. The transperineal targeted prostate biopsy procedure was accomplished via a transperineal approach and used a stepper, combined with advanced mpMRI/transrectal ultrasound fusion software, to perform targeted prostate biopsy. The detection of overall and clinically significant prostate cancer (PCa) was assessed as well as the rate of complications.

Results

The median patient age was 68.0 years and the median PSA wa

SUBMITTER: Kosarek CD 

PROVIDER: S-EPMC6151177 | biostudies-literature | 2018 Nov

REPOSITORIES: biostudies-literature